From: Management of patients with retroperitoneal tumors and a review of the literature
Region | n (%) | Mean tumor size (cm) | Metastasis status | Number = 21 (%) | Size (cm) mean |
---|---|---|---|---|---|
RUQ | 1 (3.57%) | 2 | Nodular | 5 (23.80%) | 14.2 |
RIQ | 2 (7.14%) | 10 | Liver + Nodular | 1 (4.76%) | 16 |
LUQ | 6 (21.42%) | 13.3 | Right tubo-ovarian | 1 (4.76%) | 6 |
LIQ | 6 (21.42%) | 8.8 | + Nodular | ||
LLR | 3 (10.71%) | 23.3 | Left kidney + Nodular | 1 (4.76%) | 30 |
SNT | 3 (10.71%) | 17.3 | Spleen, stomach | 1 (4.76%) | 17 |
SP | 7 (25%) | 11.5 | Aortic | 1 (4.76%) | 24 |
Aortic, VCI | 1 (4.76%) | 10 | |||
Colon | 1 (4.76%) | 8 | |||
Spleen | 1 (4.76%) | 15 | |||
None | 8 (38.1%) | 10.5 |